Standout Papers

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemother... 2008 2026 2014 2020 2.4k
  1. Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer (2008)
    Giorgio V. Scagliotti, Purvish Parikh et al. Journal of Clinical Oncology

Immediate Impact

9 by Nobel laureates 12 from Science/Nature 109 standout
Sub-graph 1 of 18

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Therapeutic resistance to anti-oestrogen therapy in breast cancer
2023 Standout
8 intermediate papers

Works of Janusz Rolski being referenced

Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study
2012
Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study
2009
and 1 more

Author Peers

Author Last Decade Papers Cites
Janusz Rolski 2802 2724 352 783 44 4.1k
Yaroslav Shparyk 2896 2285 105 937 67 3.8k
Helen Mann 4000 4433 356 1192 89 5.9k
L. Rhoda Molife 1257 1473 190 660 73 2.9k
Stacy Moulder 2580 2470 166 1521 69 4.5k
Vivien Bramwell 2374 2557 821 944 74 5.0k
Paula Marrano 1922 2208 244 834 60 3.9k
Diane Prager 3429 3407 260 724 54 5.3k
Judy Dering 2155 1294 99 895 40 3.5k
P. Lianes 2680 2638 622 488 76 4.2k
Zsuzsanna Pápai 1662 1543 234 921 91 3.1k

All Works

Loading papers...

Rankless by CCL
2026